Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 162

1.

Minimum Clinically Important Difference in 30-s Sit-to-Stand Test After Pulmonary Rehabilitation in Subjects With COPD.

Zanini A, Crisafulli E, D'Andria M, Gregorini C, Cherubino F, Zampogna E, Azzola A, Spanevello A, Schiavone N, Chetta A.

Respir Care. 2019 Jul 3. pii: respcare.06694. doi: 10.4187/respcare.06694. [Epub ahead of print]

PMID:
31270178
2.

Reduced exercise ventilatory efficiency in Cystic Fibrosis adults with normal to moderately impaired lung function.

Di Paolo M, Teopompi E, Savi D, Crisafulli E, Longo C, Tzani P, Longo F, Ielpo A, Pisi G, Cimino G, Simmonds NJ, Neder JA, Chetta A, Palange P.

J Appl Physiol (1985). 2019 Jun 20. doi: 10.1152/japplphysiol.00030.2019. [Epub ahead of print]

PMID:
31219769
3.

The value of high-resolution computed tomography (HRCT) to determine exercise ventilatory inefficiency and dynamic hyperinflation in adult patients with cystic fibrosis.

Crisafulli E, Teopompi E, Luceri S, Longo F, Tzani P, Pagano P, Ielpo A, Longo C, Di Paolo M, Sverzellati N, Palange P, Chetta A, Pisi G.

Respir Res. 2019 Apr 24;20(1):78. doi: 10.1186/s12931-019-1044-8.

4.

Non-invasive techniques to assess restrictive lung disease in workers exposed to free crystalline silica.

Corradi M, Folesani G, Robuschi B, Selis L, Riccelli MG, Riccelli MG, Andreoli R, Pisi R, Chetta A, Mutti A.

Med Lav. 2019 Apr 19;110(2):83-92. doi: 10.23749/mdl.v110i2.7471.

PMID:
30990470
5.

Overall mortality in combined pulmonary fibrosis and emphysema related to systemic sclerosis.

Ariani A, Silva M, Bravi E, Parisi S, Saracco M, De Gennaro F, Caimmi C, Girelli F, De Santis M, Volpe A, Lumetti F, Hax V, Bredemeier M, Alfieri V, Santilli D, Bodini FC, Lucchini G, Mozzani F, Seletti V, Bacchini E, Arrigoni E, Giuggioli D, Chakr R, Idolazzi L, Bertorelli G, Imberti D, Michieletti E, Paolazzi G, Fusaro E, Chetta AA, Scirè CA, Sverzellati N.

RMD Open. 2019 Feb 14;5(1):e000820. doi: 10.1136/rmdopen-2018-000820. eCollection 2019.

6.

Cough, a vital reflex. mechanisms, determinants and measurements.

Andrani F, Aiello M, Bertorelli G, Crisafulli E, Chetta A.

Acta Biomed. 2019 Jan 15;89(4):477-480. doi: 10.23750/abm.v89i4.6182.

7.

Clinical variables predicting the risk of a hospital stay for longer than 7 days in patients with severe acute exacerbations of chronic obstructive pulmonary disease: a prospective study.

Crisafulli E, Ielpo A, Barbeta E, Ceccato A, Huerta A, Gabarrús A, Soler N, Chetta A, Torres A.

Respir Res. 2018 Dec 27;19(1):261. doi: 10.1186/s12931-018-0951-4.

8.

Carfilzomib: a Tale of a Heartbreaking Moment. Case Report and Concise Review of the Literature.

Serra W, Fantin A, Longo C, Rabia G, De Rosa F, Plenteda C, Re F, Crisafulli E, Chetta A.

Cardiovasc Hematol Disord Drug Targets. 2018 Dec 4. doi: 10.2174/1871529X19666181205100705. [Epub ahead of print]

PMID:
30516116
9.

Pleuritis with pleural effusion due to a Bacillus megaterium infection.

Crisafulli E, Aredano I, Valzano I, Burgazzi B, Andrani F, Chetta A.

Respirol Case Rep. 2018 Nov 28;7(1):e00381. doi: 10.1002/rcr2.381. eCollection 2019 Jan.

10.

A High Degree of Dyspnea Is Associated With Poor Maximum Exercise Capacity in Subjects With COPD With the Same Severity of Air-Flow Obstruction.

Crisafulli E, Aiello M, Tzani P, Ielpo A, Longo C, Alfieri V, Bertorelli G, Chetta A.

Respir Care. 2019 Apr;64(4):390-397. doi: 10.4187/respcare.06336. Epub 2018 Nov 13.

PMID:
30425167
11.

Flow and volume response to bronchodilator in patients with COPD.

Vigna M, Aiello M, Bertorelli G, Crisafulli E, Chetta A.

Acta Biomed. 2018 Oct 8;89(3):332-336. doi: 10.23750/abm.v89i3.5631.

12.

Pulmonary hernia: Case report and review of the literature.

Scelfo C, Longo C, Aiello M, Bertorelli G, Crisafulli E, Chetta A.

Respirol Case Rep. 2018 Oct 2;6(8):e00354. doi: 10.1002/rcr2.354. eCollection 2018 Nov.

13.

Effect of ambulatory oxygen on quality of life for patients with fibrotic lung disease (AmbOx): a prospective, open-label, mixed-method, crossover randomised controlled trial.

Visca D, Mori L, Tsipouri V, Fleming S, Firouzi A, Bonini M, Pavitt MJ, Alfieri V, Canu S, Bonifazi M, Boccabella C, De Lauretis A, Stock CJW, Saunders P, Montgomery A, Hogben C, Stockford A, Pittet M, Brown J, Chua F, George PM, Molyneaux PL, Margaritopoulos GA, Kokosi M, Kouranos V, Russell AM, Birring SS, Chetta A, Maher TM, Cullinan P, Hopkinson NS, Banya W, Whitty JA, Adamali H, Spencer LG, Farquhar M, Sestini P, Wells AU, Renzoni EA.

Lancet Respir Med. 2018 Oct;6(10):759-770. doi: 10.1016/S2213-2600(18)30289-3. Epub 2018 Aug 28.

14.

Looking for Predictors of Early Readmission in Chronic Obstructive Pulmonary Disease: Every Effort Is Required.

Crisafulli E, Guerrero M, Ielpo A, Chetta A, Torres A.

Ann Am Thorac Soc. 2018 Nov;15(11):1366. doi: 10.1513/AnnalsATS.201807-458LE. No abstract available.

PMID:
30141969
15.

Heart rate recovery is associated with ventilatory constraints and excess ventilation during exercise in patients with chronic obstructive pulmonary disease.

Crisafulli E, Vigna M, Ielpo A, Tzani P, Mangia A, Teopompi E, Aiello M, Alfieri V, Bertorelli G, Palange P, Chetta A.

Eur J Prev Cardiol. 2018 Oct;25(15):1667-1674. doi: 10.1177/2047487318789756. Epub 2018 Jul 23.

PMID:
30033754
16.

Spot the trachea! A wide paratracheal air cyst of not easy definition.

Crisafulli E, Lazzari C, Longo C, Bernardinello N, Alfieri V, Chetta A.

Acta Biomed. 2018 Jun 7;89(2):260-261. doi: 10.23750/abm.v89i2.5610.

17.

Impact of bronchiectasis on outcomes of hospitalized patients with acute exacerbation of chronic obstructive pulmonary disease: A propensity matched analysis.

Crisafulli E, Guerrero M, Ielpo A, Ceccato A, Huerta A, Gabarrús A, Soler N, Chetta A, Torres A.

Sci Rep. 2018 Jun 18;8(1):9236. doi: 10.1038/s41598-018-27680-y.

18.

The role of the microbiome in childhood asthma.

Pisi G, Fainardi V, Aiello M, Bertorelli G, Crisafulli E, Chetta A.

Immunotherapy. 2017 Nov;9(15):1295-1304. doi: 10.2217/imt-2017-0048. Review.

PMID:
29130800
19.

Next generation beta adrenoreceptor agonists for the treatment of asthma.

Crisafulli E, Frizzelli A, Fantin A, Manco A, Mangia A, Pisi G, Fainardi V, Alfieri V, Aiello M, Bertorelli G, Chetta A.

Expert Opin Pharmacother. 2017 Oct;18(14):1499-1505. doi: 10.1080/14656566.2017.1378348. Epub 2017 Sep 14. Review.

PMID:
28891349
20.

Sarcoidosis in an Italian province. Prevalence and environmental risk factors.

Beghè D, Dall'Asta L, Garavelli C, Pastorelli AA, Muscarella M, Saccani G, Aiello M, Crisafulli E, Corradi M, Stacchini P, Chetta A, Bertorelli G.

PLoS One. 2017 May 5;12(5):e0176859. doi: 10.1371/journal.pone.0176859. eCollection 2017.

21.

Asymptomatic peripheral artery disease can limit maximal exercise capacity in chronic obstructive pulmonary disease patients regardless of airflow obstruction and lung hyperinflation.

Crisafulli E, Scelfo C, Tzani P, Aiello M, Bertorelli G, Chetta A.

Eur J Prev Cardiol. 2017 Jun;24(9):990-999. doi: 10.1177/2047487317695629. Epub 2017 Jan 1.

PMID:
28436723
22.

The earlier, the better: Impact of early diagnosis on clinical outcome in idiopathic pulmonary fibrosis.

Aiello M, Bertorelli G, Bocchino M, Chetta A, Fiore-Donati A, Fois A, Marinari S, Oggionni T, Polla B, Rosi E, Stanziola A, Varone F, Sanduzzi A.

Pulm Pharmacol Ther. 2017 Jun;44:7-15. doi: 10.1016/j.pupt.2017.02.005. Epub 2017 Feb 28. Review.

PMID:
28257817
23.

Quantitative chest computed tomography is associated with two prediction models of mortality in interstitial lung disease related to systemic sclerosis.

Ariani A, Silva M, Seletti V, Bravi E, Saracco M, Parisi S, De Gennaro F, Idolazzi L, Caramaschi P, Benini C, Bodini FC, Scirè CA, Carrara G, Lumetti F, Alfieri V, Bonati E, Lucchini G, Aiello M, Santilli D, Mozzani F, Imberti D, Michieletti E, Arrigoni E, Delsante G, Pellerito R, Fusaro E, Chetta A, Sverzellati N.

Rheumatology (Oxford). 2017 Jun 1;56(6):922-927. doi: 10.1093/rheumatology/kew480.

PMID:
28160007
24.

A Pilot Study Linking Endothelial Injury in Lungs and Kidneys in Chronic Obstructive Pulmonary Disease.

Polverino F, Laucho-Contreras ME, Petersen H, Bijol V, Sholl LM, Choi ME, Divo M, Pinto-Plata V, Chetta A, Tesfaigzi Y, Celli BR, Owen CA.

Am J Respir Crit Care Med. 2017 Jun 1;195(11):1464-1476. doi: 10.1164/rccm.201609-1765OC.

25.

Prevalence of Small-Airway Dysfunction among COPD Patients with Different GOLD Stages and Its Role in the Impact of Disease.

Crisafulli E, Pisi R, Aiello M, Vigna M, Tzani P, Torres A, Bertorelli G, Chetta A.

Respiration. 2017;93(1):32-41. Epub 2016 Nov 17.

26.

Transthoracic Echocardiography and Chest Computed Tomography Arteriography in Patients with Acute Pulmonary Embolism: A Two-Year Follow-Up Study.

Serra W, Crisafulli E, Sverzellati N, Ugolotti PT, Tzani P, Marangio E, Ardissino D, Gherli T, Chetta A.

Respiration. 2016;92(4):235-240. Epub 2016 Sep 8.

27.

Relationships between emphysema and airways metrics at High-Resolution Computed Tomography (HRCT) and ventilatory response to exercise in mild to moderate COPD patients.

Crisafulli E, Alfieri V, Silva M, Aiello M, Tzani P, Milanese G, Bertorelli G, Sverzellati N, Chetta A.

Respir Med. 2016 Aug;117:207-14. doi: 10.1016/j.rmed.2016.06.016. Epub 2016 Jun 21.

28.

Readmission in COPD patients: should we consider it a marker of quality of care or a marker of a more severe disease with a worse prognosis?

Crisafulli E, Guerrero M, Chetta A, Torres A.

Eur Respir J. 2016 Jul;48(1):279-81. doi: 10.1183/13993003.00426-2016. No abstract available.

29.

Are interstitial lung abnormalities associated with COPD? A nested case-control study.

Bozzetti F, Paladini I, Rabaiotti E, Franceschini A, Alfieri V, Chetta A, Crisafulli E, Silva M, Pastorino U, Sverzellati N.

Int J Chron Obstruct Pulmon Dis. 2016 May 26;11:1087-96. doi: 10.2147/COPD.S103256. eCollection 2016.

30.

Left ventricular structure and remodeling in patients with COPD.

Pelà G, Li Calzi M, Pinelli S, Andreoli R, Sverzellati N, Bertorelli G, Goldoni M, Chetta A.

Int J Chron Obstruct Pulmon Dis. 2016 May 13;11:1015-22. doi: 10.2147/COPD.S102831. eCollection 2016.

31.

Readmission for Acute Exacerbation within 30 Days of Discharge Is Associated with a Subsequent Progressive Increase in Mortality Risk in COPD Patients: A Long-Term Observational Study.

Guerrero M, Crisafulli E, Liapikou A, Huerta A, Gabarrús A, Chetta A, Soler N, Torres A.

PLoS One. 2016 Mar 4;11(3):e0150737. doi: 10.1371/journal.pone.0150737. eCollection 2016.

32.

Inhaled beclometasone dipropionate/formoterol fumarate extrafine fixed combination for the treatment of asthma.

Crisafulli E, Zanini A, Pisi G, Pignatti P, Poli G, Scuri M, Chetta A.

Expert Rev Respir Med. 2016;10(5):481-90. doi: 10.1586/17476348.2016.1161508. Epub 2016 Mar 16. Review.

PMID:
26938578
33.

Quantitative CT indexes are significantly associated with exercise oxygen desaturation in interstitial lung disease related to systemic sclerosis.

Ariani A, Aiello M, Silva M, Alfieri V, Bonati E, Lumetti F, Delsante G, Sverzellati N, Chetta A.

Clin Respir J. 2017 Nov;11(6):983-989. doi: 10.1111/crj.12451. Epub 2016 Feb 22.

PMID:
26899794
34.

Exhaled and non-exhaled non-invasive markers for assessment of respiratory inflammation in patients with stable COPD and healthy smokers.

Santini G, Mores N, Shohreh R, Valente S, Dabrowska M, Trové A, Zini G, Cattani P, Fuso L, Mautone A, Mondino C, Pagliari G, Sala A, Folco G, Aiello M, Pisi R, Chetta A, Losi M, Clini E, Ciabattoni G, Montuschi P.

J Breath Res. 2016 Jan 27;10(1):017102. doi: 10.1088/1752-7155/10/1/017102.

35.

Mepolizumab in the treatment of severe eosinophilic asthma.

Fainardi V, Pisi G, Chetta A.

Immunotherapy. 2016;8(1):27-34. doi: 10.2217/imt.15.102. Epub 2015 Dec 10. Review.

PMID:
26653083
36.

The one repetition maximum test and the sit-to-stand test in the assessment of a specific pulmonary rehabilitation program on peripheral muscle strength in COPD patients.

Zanini A, Aiello M, Cherubino F, Zampogna E, Azzola A, Chetta A, Spanevello A.

Int J Chron Obstruct Pulmon Dis. 2015 Nov 11;10:2423-30. doi: 10.2147/COPD.S91176. eCollection 2015.

37.

Alexithymia and self-reflectiveness in bronchial asthma.

Innamorati M, Chetta A, Antonucci C, Bettini E, Aiello M, Montali A, Parisoli C, Belvederi Murri M, Brugnoli R, Pisi R, Pompili M, Amore M.

Riv Psichiatr. 2015 Sep-Oct;50(5):245-52. doi: 10.1708/2040.22168.

PMID:
26489074
38.

Small airway dysfunction and flow and volume bronchodilator responsiveness in patients with chronic obstructive pulmonary disease.

Pisi R, Aiello M, Zanini A, Tzani P, Paleari D, Marangio E, Spanevello A, Nicolini G, Chetta A.

Int J Chron Obstruct Pulmon Dis. 2015 Jun 19;10:1191-7. doi: 10.2147/COPD.S82509. eCollection 2015.

39.

Effects of Pulmonary Rehabilitation in Patients with Non-Cystic Fibrosis Bronchiectasis: A Retrospective Analysis of Clinical and Functional Predictors of Efficacy.

Zanini A, Aiello M, Adamo D, Cherubino F, Zampogna E, Sotgiu G, Chetta A, Spanevello A.

Respiration. 2015;89(6):525-33. doi: 10.1159/000380771. Epub 2015 Apr 28.

40.

Estimation of minimal clinically important difference in EQ-5D visual analog scale score after pulmonary rehabilitation in subjects with COPD.

Zanini A, Aiello M, Adamo D, Casale S, Cherubino F, Della Patrona S, Raimondi E, Zampogna E, Chetta A, Spanevello A.

Respir Care. 2015 Jan;60(1):88-95. doi: 10.4187/respcare.03272. Epub 2014 Oct 21.

41.

Mepolizumab treatment in patients with severe eosinophilic asthma.

Ortega HG, Liu MC, Pavord ID, Brusselle GG, FitzGerald JM, Chetta A, Humbert M, Katz LE, Keene ON, Yancey SW, Chanez P; MENSA Investigators.

N Engl J Med. 2014 Sep 25;371(13):1198-207. doi: 10.1056/NEJMoa1403290. Epub 2014 Sep 8. Erratum in: N Engl J Med. 2015 Apr 30;372(18):1777.

42.

Small airway dysfunction is associated to excessive bronchoconstriction in asthmatic patients.

Alfieri V, Aiello M, Pisi R, Tzani P, Mariani E, Marangio E, Olivieri D, Nicolini G, Chetta A.

Respir Res. 2014 Aug 27;15:86. doi: 10.1186/s12931-014-0086-1.

43.

The value of cough peak flow in the assessment of cough efficacy in neuromuscular patients. A cross sectional study.

Tzani P, Chiesa S, Aiello M, Scarascia A, Catellani C, Elia D, Marangio E, Chetta A.

Eur J Phys Rehabil Med. 2014 Aug;50(4):427-32. Epub 2014 Jun 3.

44.

Pulmonary arterial hypertension in childhood: an unsual presentation with fibrosing mediastinitis.

Teopompi E, Tchana B, Chetta A, Aiello M, Sgrignoli M, Carano N, Agnetti A.

Acta Biomed. 2014 May 9;85(1):68-72.

PMID:
24897974
45.

Maximal exercise in obese patients with COPD: the role of fat free mass.

Aiello M, Teopompi E, Tzani P, Ramponi S, Gioia MR, Marangio E, Chetta A.

BMC Pulm Med. 2014 May 30;14:96. doi: 10.1186/1471-2466-14-96.

46.

Excess ventilation and ventilatory constraints during exercise in patients with chronic obstructive pulmonary disease.

Teopompi E, Tzani P, Aiello M, Gioia MR, Marangio E, Chetta A.

Respir Physiol Neurobiol. 2014 Jun 15;197:9-14. doi: 10.1016/j.resp.2014.03.002. Epub 2014 Mar 19.

PMID:
24657545
47.

Six-minute walking distance improvement after pulmonary rehabilitation is associated with baseline lung function in complex COPD patients: a retrospective study.

Zanini A, Chetta A, Gumiero F, Della Patrona S, Casale S, Zampogna E, Aiello M, Spanevello A.

Biomed Res Int. 2013;2013:483162. doi: 10.1155/2013/483162. Epub 2013 Dec 18.

48.

Decreased maturation of dendritic cells in the central airways of COPD patients is associated with VEGF, TGF-β and vascularity.

Zanini A, Spanevello A, Baraldo S, Majori M, Della Patrona S, Gumiero F, Aiello M, Olivieri D, Saetta M, Chetta A.

Respiration. 2014;87(3):234-42. doi: 10.1159/000356749. Epub 2014 Jan 14.

49.

Cardiovascular function in pulmonary emphysema.

Visca D, Aiello M, Chetta A.

Biomed Res Int. 2013;2013:184678. doi: 10.1155/2013/184678. Epub 2013 Dec 3. Review.

50.

What we talk about when we talk about randomized controlled trials.

Chetta A, Olivieri D.

Respiration. 2014;87(1):9-10. doi: 10.1159/000355704. Epub 2013 Nov 23. No abstract available.

Supplemental Content

Loading ...
Support Center